Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

NeuroPace (NPCE) EBIAT (2020 - 2025)

NeuroPace (NPCE) has 6 years of EBIAT data on record, last reported at -$2.7 million in Q4 2025.

  • For Q4 2025, EBIAT rose 48.02% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached -$21.5 million, up 20.91%, while the annual FY2025 figure was -$21.5 million, 20.91% up from the prior year.
  • EBIAT reached -$2.7 million in Q4 2025 per NPCE's latest filing, up from -$3.5 million in the prior quarter.
  • Across five years, EBIAT topped out at -$2.7 million in Q4 2025 and bottomed at -$12.7 million in Q2 2022.
  • Average EBIAT over 5 years is -$8.2 million, with a median of -$8.6 million recorded in 2021.
  • Peak YoY movement for EBIAT: tumbled 131.55% in 2021, then skyrocketed 48.02% in 2025.
  • A 5-year view of EBIAT shows it stood at -$10.7 million in 2021, then dropped by 4.24% to -$11.1 million in 2022, then skyrocketed by 44.37% to -$6.2 million in 2023, then grew by 15.32% to -$5.2 million in 2024, then surged by 48.02% to -$2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$2.7 million in Q4 2025, -$3.5 million in Q3 2025, and -$8.7 million in Q2 2025.